Status:
UNKNOWN
Gene Expression in Monocytes of Growth Hormone Deficient Children
Lead Sponsor:
University of Salerno
Conditions:
Growth Hormone Deficiency
Eligibility:
MALE
6-10 years
Brief Summary
The Growth hormone (GH) is mainly synthesized in the anterior portion of the pituitary gland and has an effect on different body areas. Secreted in the circulatory stream, growth hormone reaches the l...
Eligibility Criteria
Inclusion
- Height lower the 3th percentile
Exclusion
- Any endocrinopathy
- Liver, kidney or haemolymphopoietic system disorders
- Celiac disease or other chronic malabsorption conditions
- Genetic syndromes (such as Turner's S., Cystic fibrosis or Down S.)
- Drug therapies interfering with growth
Key Trial Info
Start Date :
April 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 15 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04352712
Start Date
April 15 2019
End Date
April 15 2021
Last Update
May 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine and Surgery, Univeristy of Salerno
Baronissi, Salerno, Italy, 84081